Latest News

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In XTI Aerospace To Contact Him Directly To Discuss Their Options If you purchased or ac

Shares of FuelCell Energy Inc. (NASDAQ:FCEL) are trading higher Friday morning, attempting a modest rebound following recent selloffs as investors evaluate long-term AI data center power demand agains

Funding Circle Holdings PLC (LSE:FCH) received renewed backing from Cavendish, which called the share-price retreat a buying opportunity despite uncertainty over the chief executive's planned departur

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Flotek Industries To Contact Him Directly To Discuss Their Options If you purchased o

Adobe delivered a double beat on revenue and EPS, with robust 12.9% Y/Y growth and raised FY26 guidance. Firefly ARR surged 40% sequentially, Creative freemium MAU crossed 100M, and total MAU exceeded

Micron Technology, Inc. remains a bullish opportunity ahead of Q4 earnings, with upside potential of 32% to my price target. Fears of a cyclical memory peak are overblown; capacity constraints and pe

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ARS Pharmaceuticals To Contact Him Directly To Discuss Their Options If you purchased

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Innventure To Contact Him Directly To Discuss Their Options If you purchased or acqui

SpaceX wants a piece of the cellphone market, but T-Mobile's CFO is far from concerned. Peter Osvaldik said "everybody in the know" is "laughing" at parts of Starlink's plans.

Microsoft TodayMSFTMicrosoft$492.44 +0.79 (+0.16%) As of 09/10/2026 04:00 PM Eastern52-Week Range$349.20▼$553.72Dividend Yield0.74%P/E Ratio27.42Price Target$564.27Add to WatchlistA company's quarterl

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hyliion To Contact Him Directly To Discuss Their Options If you purchased or acquired

Inovio Pharmaceuticals NASDAQ: INO said its biologics license application for INO-3107, an investigational DNA medicine for recurrent respiratory papillomatosis, or RRP, remains under U.S. Food and Dr

INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of AtaiBeckley Inc. AtaiBeckley is a clinical-stage biopharm

Management to Meet with Investors and Highlight Progress and Future Development Plans for PH-762 King of Prussia, Pennsylvania--(Newsfile Corp. - September 11, 2026) - Phio Pharmaceuticals Corp. (NASD

TAMPA, Fla., Sept. 11, 2026 /PRNewswire/ -- Crown Holdings, Inc. (NYSE: CCK) celebrated on September 9, 2026 the groundbreaking of its first beverage can manufacturing facility in India, marking a maj

MILFORD, Mass., Sept. 11, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.

Toby Neugebauer says the Board must act quickly to restore stakeholder confidence. Shares down roughly 20% since Board announced they had met all 90-day objectives on August 13, 35% since the Board re

Aya Gold & Silver (AYA) is rated a value Buy, supported by robust financials, credible growth plans, and strong silver market tailwinds. Zgounder mine drives current revenues, funding expansion, with

Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Argo Gold Inc. (CSE: ARQ) (OTC Pink: ARBTF) (XFRA: A2ASDS) (XSTU: A2ASDS) (XBER: A2ASDS) ("Argo" or the "Company") announces that it has compl

Northrop Grumman is a Buy at current levels, supported by structural defense tailwinds and major roles in U.S. nuclear modernization and space. NOC offers durable value amid great-power rivalry, but g